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Aim. To evaluate the potential of thermography as an assessment tool for the detection of foot complications by understanding the
variations in temperature that occur in type 2 diabetes mellitus (DM). Methods. Participants were categorized according to a
medical examination, ankle brachial index, doppler waveform analysis, and 10-gram monoﬁlament testing into ﬁve groups: healthy
adult, DM with no complications, DM with peripheral neuropathy, DM with neuroischaemia, and DM with peripheral arterial
disease (PAD) groups. Thermographic imaging of the toes and forefeet was performed. Results. 43 neuroischaemic feet, 41
neuropathic feet, 58 PAD feet, 21 DM feet without complications, and 126 healthy feet were analyzed. The temperatures of the feet
and toes were signiﬁcantly higher in the complications group when compared to the healthy adult and DM healthy groups. The
higher the temperatures of the foot in DM, the higher the probability that it is aﬀected by neuropathy, neuroischaemia, or PAD.
Conclusions. Signiﬁcant diﬀerences in mean temperatures exist between participants who were healthy and those with DM with no
known complications when compared to participants with neuroischaemia, neuropathy, or PAD. As foot temperature rises,
so does the probability of the presence of complications of neuropathy, neuroischaemia, or peripheral arterial disease.
1. Introduction
The diabetic foot is characterized by the presence of various
complications that typically tend to develop as a result of
poor glycaemic control. The main complications include
neuropathy, peripheral arterial disease (PAD), and neu-
roischaemia, amongst others. These complications are
amongst the most serious and costly as they often lead to
amputation. In many cases, development of diabetic foot
complications can be avoided or substantially delayed with
timely assessment, diagnosis, and treatment provided at an
early stage of the disease. Prophylactic foot care has been
shown to decrease patient morbidity [1].
Common diabetic foot complications such as ischae-
mia and neuropathy have an eﬀect on the temperature
of the foot [2]. It is postulated that changes in tempera-
ture of the foot may be indicative of the presence of
such complications.
Thermography or medical infrared imaging may be used
to detect temperature changes. This technique is deemed safe
since it is noncontact, noninvasive, and nonirradiant and has
been utilized in a number of medical applications including
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imaging of the breast [3], skin [4] and foot vascular compli-
cations, and ulceration in diabetes [5–7].
The current clinical practice of temperature assessment is
mainly by manual palpation of foot temperature. However, a
gradual increase in foot temperature may be too subtle to be
detected only by the hand, making the timely and early
detection of underlying pathology diﬃcult. It has been
established that increased temperatures in the foot may be
present up to a week before a foot ulcer occurs [8], thus
making it important for any variations in temperature to be
detected promptly.
Thermal imaging oﬀers an excellent means of making a
quantitative determination of surface temperature and can
oﬀer an alternative mode of detection of major foot compli-
cations since it has been reported that monitoring of skin
temperature reduces the risk of diabetic foot ulceration in
high-risk patients [9].
Although Nagase et al. had looked at variations in plantar
thermographic patterns in normal controls and nonulcer dia-
betic patients, it has not been fully elucidated to what extent
the individual variations of the plantar thermographic pat-
terns show diﬀerent trends between these two cohorts [10].
Presently, little is known about the range of abnormal
thermoregulation in those patients with diabetes present-
ing both for screening and management [8]. The aim of
this study was to evaluate the potential of thermography
as an assessment tool for the detection of type 2 diabetic
foot disease by assessing the variations in temperature that
occur in the diabetic foot before ulceration appears. Objec-
tives were to ﬁnd a possible correlation between temperature
readings of the plantar foot and toes in diabetic foot compli-
cations to reduce the risk of foot ulceration by early detection
of pathologies.
2. Method
This study employed medical infrared imaging to visualize
the temperature distribution of the feet of participants living
with DM with or without complications and healthy
controls. Following ethical approval from the University
Ethics Committee, initially, healthy adult participants were
recruited, medically examined, and imaged as reported else-
where [11] whilst participants with type 2 diabetes mellitus
were recruited from the patient list of a vascular surgeon.
All participants underwent a thorough clinical examination
that included validated tests for neuropathy [12] and periph-
eral arterial disease [13].
Participants with DM were categorized into 4 groups
based on the medical examination and testing: a heathy
DM group (i.e., presenting with DM but no signiﬁcant
medical comorbidities and/or complications), a PAD group
(presenting with ABPI< 0.6 and monophasic Doppler
spectral waveforms at the ankles, but no neuropathy), a neu-
ropathic group (presenting with positive 10-gram monoﬁla-
ment at any one of 10 tested sites and/or reduced vibration
perception threshold as measured with a tuning fork and an
ABPI between 0.9 and 1.3), and a neuroischaemic group
(presenting with ABPI< 0.9 and neuropathy).
Participants who presented with active ulceration or
other signiﬁcant comorbidities that could aﬀect the distribu-
tion of thermographic patterns, such as rheumatoid arthritis
or Raynaud’s phenomenon, were excluded.
Following a 15-minute acclimatization period, all partic-
ipants rested in a supine position on a couch in a room which
was temperature controlled at 23°C.
An ABPI was obtained [14, 15], according to standard
clinical practice utilizing a Huntleigh (Cardiﬀ, Wales) Dop-
plex Assist. A cuﬀ was applied proximal to the ankle, and
an 8Mhz doppler probe was applied at the posterior tibial
artery and the dorsalis paedis artery. The probe was held at
an angle of 45° against blood ﬂow while the cuﬀ was inﬂated
until the doppler signal was cut oﬀ. Then the cuﬀ pressure
was slowly released. Once the signal was reobtained, the
systolic pressure of the particular artery was noted.
This process was repeated for the brachial artery; the cuﬀ
was applied above the elbow and the doppler probe was held
in order to obtain its systolic pressure. The ABPI was calcu-
lated with the higher of the posterior tibial and dorsalis pae-
dis pressures being taken into consideration. Normal ABPI
values ranged from 0.9 to 1.3.
Spectral Doppler waveform analysis was also employed
to classify the recorded waveform as being triphasic, biphasic,
or monophasic [16]. A triphasic waveform is indicative of
normal arterial perfusion, whilst the other two classiﬁcations
are indicative of PAD, with the monophasic waveform
denoting a more severe form of the condition. Only those
participants with monophasic waveforms and an ABPI< 0.6
were included to ensure an unequivocal diagnosis of PAD.
Testing for neuropathy involved the use of a 10 g Semmes
Weinstein monoﬁlament administered at 10 sites on each
foot. In this validated method, exactly 10 g of force was
applied before the monoﬁlament bent, thus ensuring that
exactly the same amount of force is applied. Neuropathy
was diagnosed if at least one site was not felt by the partici-
pant. All the above measurements were carried out by the
same experienced clinician in order to ensure consistency.
3. Image Acquisition, Segmentation, Data
Extraction, and Analysis
A FLIR SC7200 infrared camera with a spatial resolution of
320× 256 pixels and a temperature resolution of 20mK was
used for the acquisition of thermal images. The protocol for
obtaining thermal images followed the recommendations of
the American Academy of Thermology [17]. The camera
was placed on a tripod 1.5m from the subject and perpen-
dicular to the body part that was being photographed [11].
Images of the plantar aspect of the feet were recorded for
later analysis.
Thermal images obtained of the feet were divided into
regions so that temperature data could be extracted
(Figures 1(a) and 1(b)) [11].
4. Results
Thermographic images from 43 neuroischaemic limbs (from
30 subjects), 41 neuropathic limbs (from 32 subjects),
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58 PAD limbs (from 42 subjects), 21 DM healthy limbs
(15 subjects,), and 126 healthy limbs (from 63 subjects)
were analyzed.
When analyzing the mean temperature data in all 5 toes
and 3 plantar regions of the forefoot (medial, central, and
lateral regions) (Figures 2 and 3), there are signiﬁcant
Figure 2: Toe temperature distribution.
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Figure 1: (a) Diagram showing the foot regions considered for temperature extraction. (b) An actual thermal image and the corresponding
regions of interest. The temperatures from the toe regions and forefoot regions were considered for further analysis.
Figure 3: Forefoot temperature distribution.
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diﬀerences in mean temperatures between the ﬁve groups of
patients, as demonstrated by the Tukey test (Table 1). This
test clusters these ﬁve groups into two groups where the
mean temperatures of diabetic participants with peripheral
arterial disease, diabetes patients with neuropathy, and dia-
betes patients with neuroischaemia are signiﬁcantly higher
than the mean temperatures of healthy adults and diabetes
patients with no known complication. Thus, for further
statistical comparison, these ﬁve categories were divided into
a “healthy group” (comprised of healthy adults and DM
participants with no known complications) and a “complica-
tions group” (comprised of neuropathic, neuroischaemic,
and PAD participants).
5. Logistic Regression Analysis
In the ﬁrst logistic regression model ﬁt, we relate the health
status (neuropathic, neuroischaemic, or PAD; healthy or
DM healthy) to two predictors, which include toe tempera-
ture and toe location. As indicated in Table 2, a binomial
distribution is assumed since the dependent variable has
two categories, while a logit link function is used since this
is the canonical link for the binomial distribution.
Toe location was not found to be a signiﬁcant predictor
since the p value (0.901) exceeds the 0.05 level of signiﬁcance.
Abackwardprocedurewasused toﬁt theparsimoniousmodel,
which identiﬁed temperature as a sole signiﬁcant predictor.
As shown in Table 3, the regression coeﬃcient of temper-
ature (0.220) is positive indicating that the toe temperature of
neuropathic, neuroischaemic, or PAD participants is
expected to be higher than that of healthy or DM healthy
patients. The odds ratio indicates that the odds that the
participant has neuropathy, neuroischaemia, or PAD rather
than being healthy increases by 24.7% for every 1°C increase
in toe temperature. This odds ratio ranges from 19.8% to
29.7% assuming a 95% conﬁdence level. The logistic
regression model that yields the probability that a patient
has neuropathy, neuroischaemia, or PAD given the toe tem-
perature is given by
loge
p
1 − p = −5 786 + 0 220 temperature, 1
where p is the probability that the participant has neurop-
athy, neuroischaemia, or PAD and 1 − p is the probability
that the patient is healthy. The probability curves dis-
played in Figure 4 clearly show that the likelihood of neu-
ropathy, neuroischaemia, or PAD increases as the toe
temperature increases.
In the second logistic regression model ﬁt, we relate
the health status (neuropathic, neuroischaemic, or PAD;
healthy or DM healthy) to two predictors, which include
temperature and forefoot location, whether medial, central,
or lateral. A binomial distribution and a logit link function
are again assumed.
Plantar location was not found to be a signiﬁcant predic-
tor since the p value (0.912) exceeds the 0.05 level of
signiﬁcance. A backward procedure was used to ﬁt the parsi-
monious model, which identiﬁed temperature as a sole
signiﬁcant predictor (Table 4).
The results in Table 5 indicate that the regression coeﬃ-
cient for the plantar forefoot temperature (0.254) is positive
Table 1: Tukey test to compare mean temperatures between the two groups.
Sample size Mean Std. deviation p value
Toe 1
Neuropathic, neuroischaemic, and PAD 121 27.83 2.637
0.000
Healthy and DM healthy 123 25.52 3.473
Toe 2
Neuropathic, neuroischaemic, and PAD 128 27.38 2.899
0.000
Healthy and DM healthy 122 25.12 3.452
Toe 3
Neuropathic, neuroischaemic, and PAD 131 27.33 2.886
0.000
Healthy and DM healthy 123 25.19 3.476
Toe 4
Neuropathic, neuroischaemic, and PAD 125 27.27 2.926
0.000
Healthy and DM healthy 123 25.21 3.317
Toe 5
Neuropathic, neuroischaemic, and PAD 125 27.29 2.852
0.000
Healthy and DM healthy 123 25.38 3.238
Medial forefoot
Neuropathic, neuroischaemic, and PAD 135 28.67 2.454
0.000
Healthy and DM healthy 123 26.88 2.874
Central forefoot
Neuropathic, neuroischaemic, and PAD 134 28.35 2.474
0.000
Healthy and DM healthy 123 26.68 2.835
Lateral forefoot
Neuropathic, neuroischaemic, and PAD 130 28.58 2.374
0.000
Healthy and DM healthy 123 26.80 2.861
Table 2: Likelihood ratio tests (model 1).
Likelihood ratio tests
Eﬀect
Model ﬁtting criteria Likelihood ratio tests
−2 log likelihood Chi-square df p value
Intercept 1495.659 0.000 0 .
Temperature 1634.676 139.02 1 0.000
Toe location 1496.714 1.055 4 0.901
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indicating that the plantar forefoot temperature of neuro-
pathic, neuroischaemic, or PAD patients is expected to
be higher than that of healthy or DM healthy patients. The
odds ratio indicates that the odds that the participant has
neuropathy, neuroischaemia, or PAD rather than being
healthy increases by 28.9% for every 1°C increase in plantar
temperature. This odds ratio ranges from 19.8% to 29.7%
assuming a 95% conﬁdence level. The logistic regression
model that yields the probability that a patient has neuropa-
thy, neuroischaemia, or PAD given the plantar temperature
is given by
loge
p
1 − p = −6 949 + 0 254 temperature, 2
where p is the probability that the patient has neuropathy,
neuroischaemia, or PAD and 1 − p is the probability that
the patient is healthy. The probability curves displayed in
Figure 5 clearly show that the likelihood of neuropathy,
neuroischaemia, or PAD increases as the plantar forefoot
temperature increases.
6. Discussion
The results of this thermographic study demonstrate three
main inferences: (i) that there are no signiﬁcant diﬀerences
in mean temperatures of the toes and forefoot between
healthy subjects and patients with diabetes showing no com-
plications; (ii) that there are no signiﬁcant diﬀerences in
mean temperatures of these same areas between participants
with complications of neuropathy, neuroischaemia, and
PAD; (iii) that there are signiﬁcantly higher mean tempera-
tures in these latter group of subjects when compared to both
healthy and DM participants with no complications.
This increase in temperature is further conﬁrmed by the
logistic regression models of both toe and forefoot areas,
which establish temperature as being the sole signiﬁcant pre-
dictor of complications. These models demonstrate that the
probability of complications of PAD, neuropathy, and/or
neuroischaemia being present increases as the temperature
of these regions rises.
This study is the ﬁrst of its kind to report temperature dif-
ferences between possible categories of complications of DM
relative to healthy adults. The authors recommend that these
ﬁndings and thermographic techniques should be considered
for further clinical investigations of the DM patient. These
results imply that should a rise in temperature be detected
in the diabetic foot, there is a higher likelihood that diabetic
foot complications have set in, as further reported by Sun
et al. [8] who state that thermographic patterns may change
as early as one week prior to ulceration. The ﬁndings of the
study indicate that an increase in temperature may not
necessarily imply impending ulceration, but simply the
development of peripheral neuropathy, ischaemia, or both.
Further research is warranted to establish whether the
inclusion of thermography into screening protocols could
help detect the development of diabetic foot complications
earlier so that appropriate prompt preventative measures
may be taken to avoid unnecessary complications.
Whilst neuropathic feet have been previously reported as
being warmer than healthy feet, we can now conﬁrm that
even neuroischaemic and ischaemic feet exhibit the same
trend. This may be due to altered thermoregulatory mecha-
nisms of the feet, which can be aﬀected by both neuropathy
and PAD. Local ischaemia may lead to disruption of sympa-
thetically mediated noradrenergic vasoconstriction which
leads to increased ﬂow to the cutaneous vessels rather than
through the deeper nutritive vessels which in turn leads to
Table 3: Parameter estimates of the logistic regression model for toe temperatures.
Eﬀect B Std. error Wald p value Odds ratio
95% CI for odds ratio
Lower bound Upper bound
Intercept −5.786 0.534 117.363 0.000
Temperature 0.220 0.020 119.693 0.000 1.247 1.198 1.297
3534333231302928272625
1.0
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Temperature (degree celsius)
Figure 4: Logistical regression curves of toe temperatures.
Table 4: Likelihood ratio tests (model 2).
Likelihood ratio tests
Eﬀect
Model ﬁtting criteria Likelihood ratio tests
−2 log likelihood Chi-square df p value
Intercept 924.056 0.000 0 .
Temperature 1004.520 80.464 1 0.000
Plantar forefoot
location
924.240 0.184 2 0.912
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higher heat emissivity. Arteriovenous anastamoses (AVA)
which are thick-walled, low resistance conduits allow high-
ﬂow rates directly from arterioles to venules. AVA are
numerous and richly innervated by sympathetic vasocon-
strictor nerves. Substantial changes occur in blood ﬂow
depending on whether AVAs are closed or open [18].
It is reported that the application of clinical examina-
tion or nerve conduction studies alone is not adequate in
screening diabetic at-risk feet at early stage [8]; thus, the
use of an adjunct method such as thermography may
prove useful.
Further research into thermographic patterns of patients
with diabetes and with active ulcers may help elucidate the
natural history of development of ulceration.
7. Conclusions
This study has conﬁrmed that the mean temperatures of
the toes and forefeet of the complications group exhibit
signiﬁcantly higher temperatures than those of the healthy
group, whilst each group presents with comparable tem-
peratures within themselves. These results indicate that
thermography demonstrates potential as a screening or
clinical investigation tool, although more research in the
area is warranted.
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